Maravai Lifesciences Holdings (MRVI) EBIAT (2020 - 2025)
Historic EBIAT for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$45.1 million.
- Maravai Lifesciences Holdings' EBIAT rose 7387.32% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 3391.36%. This contributed to the annual value of -$259.6 million for FY2024, which is 8762.2% down from last year.
- Latest data reveals that Maravai Lifesciences Holdings reported EBIAT of -$45.1 million as of Q3 2025, which was up 7387.32% from -$69.8 million recorded in Q2 2025.
- Maravai Lifesciences Holdings' 5-year EBIAT high stood at $156.7 million for Q2 2022, and its period low was -$172.5 million during Q3 2024.
- In the last 5 years, Maravai Lifesciences Holdings' EBIAT had a median value of -$11.9 million in 2023 and averaged $20.7 million.
- Its EBIAT has fluctuated over the past 5 years, first soared by 922711.51% in 2021, then plummeted by 158249.26% in 2024.
- Maravai Lifesciences Holdings' EBIAT (Quarter) stood at $127.1 million in 2021, then tumbled by 31.22% to $87.4 million in 2022, then crashed by 225.8% to -$110.0 million in 2023, then surged by 58.11% to -$46.1 million in 2024, then rose by 2.19% to -$45.1 million in 2025.
- Its EBIAT stands at -$45.1 million for Q3 2025, versus -$69.8 million for Q2 2025 and -$52.9 million for Q1 2025.